Cargando…

Targeting RIPK1,2,3 to combat inflammation

Detalles Bibliográficos
Autores principales:	Bullock, Alex N., Degterev, Alexei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741430/ https://www.ncbi.nlm.nih.gov/pubmed/26472031

Ejemplares similares

Targeting RIPK1 for the treatment of human diseases
por: Degterev, Alexei, et al.
Publicado: (2019)

Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors
por: Suebsuwong, Chalada, et al.
Publicado: (2018)

Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors
por: Canning, Peter, et al.
Publicado: (2015)

Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling
por: Hrdinka, Matous, et al.
Publicado: (2018)

Constitutive Interferon Attenuates RIPK1/3-Mediated Cytokine Translation
por: Muendlein, Hayley I., et al.
Publicado: (2020)

ZBP1 promotes inflammatory responses downstream of TLR3/TLR4 via timely delivery of RIPK1 to TRIF
por: Muendlein, Hayley I., et al.
Publicado: (2022)

RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications
por: Ke, Dan, et al.
Publicado: (2023)

ZBP1 promotes LPS-induced cell death and IL-1β release via RHIM-mediated interactions with RIPK1
por: Muendlein, Hayley I., et al.
Publicado: (2021)

Targeting RIPK1 kinase for modulating inflammation in human diseases
por: Li, Wanjin, et al.
Publicado: (2023)

The Role of RIPK1 and RIPK3 in Cardiovascular Disease
por: DeRoo, Elise, et al.
Publicado: (2020)

RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis
por: Zelic, Matija, et al.
Publicado: (2021)

Ripk1 and haematopoiesis: a case for LUBAC and Ripk3
por: Annibaldi, Alessandro, et al.
Publicado: (2018)

Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor
por: Delanghe, Tom, et al.
Publicado: (2021)

Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation
por: Duan, Xiaoru, et al.
Publicado: (2020)

Genetic inhibition of RIPK3 ameliorates functional outcome in controlled cortical impact independent of necroptosis
por: Wu, Limin, et al.
Publicado: (2021)

HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2
por: Wagner, Roland N., et al.
Publicado: (2015)

RIPK1 blocks T cell senescence mediated by RIPK3 and caspase-8
por: Imanishi, Takayuki, et al.
Publicado: (2023)

RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
por: Newton, K, et al.
Publicado: (2016)

Kill Two Birds with One Stone: Role of the RIPK-3 in Necroptosis and Inflammasome Activation
por: Paudel, Sagar, et al.
Publicado: (2021)

TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1
por: Moujalled, D M, et al.
Publicado: (2013)

Identification of MYC as an antinecroptotic protein that stifles RIPK1–RIPK3 complex formation
por: Seong, Daehyeon, et al.
Publicado: (2020)

Primidone blocks RIPK1-driven cell death and inflammation
por: Riebeling, Theresa, et al.
Publicado: (2020)

TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer
por: Lin, Penghang, et al.
Publicado: (2023)

Epithelial Gab1 calibrates RIPK3-dependent necroptosis to prevent intestinal inflammation
por: Xu, Jiaqi, et al.
Publicado: (2023)

RIPK1–RIPK3–MLKL-Associated Necroptosis Drives Leishmania infantum Killing in Neutrophils
por: Barbosa, Laiana A., et al.
Publicado: (2018)

TRADD regulates perinatal development and adulthood survival in mice lacking RIPK1 and RIPK3
por: Dowling, John P., et al.
Publicado: (2019)

RIPK1 prevents aberrant ZBP1-initiated necroptosis
por: Berghe, Tom Vanden, et al.
Publicado: (2016)

Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1
por: Peng, Ruoshi, et al.
Publicado: (2022)

RIPK2: a promising target for cancer treatment
por: You, Jieqiong, et al.
Publicado: (2023)

RIPK1-RIPK3-MLKL-dependent necrosis promotes the aging of mouse male reproductive system
por: Li, Dianrong, et al.
Publicado: (2017)

SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation
por: Yan, Lingjie, et al.
Publicado: (2022)

Using 1.2.3 /
Publicado: (1987)

1,2,3-Triazoles
por: Rachwal, S., et al.
Publicado: (2008)

Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation
por: Speir, Mary, et al.
Publicado: (2019)

Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell death
por: Frank, Daniel, et al.
Publicado: (2022)

RIPK1-RIPK3 mediates myocardial fibrosis in type 2 diabetes mellitus by impairing autophagic flux of cardiac fibroblasts
por: Qiao, Shigang, et al.
Publicado: (2022)

Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death
por: Moriwaki, K, et al.
Publicado: (2015)

Catecholamine Surges Cause Cardiomyocyte Necroptosis via a RIPK1–RIPK3-Dependent Pathway in Mice
por: Wu, Penglong, et al.
Publicado: (2021)

Investigation on the expression regulation of RIPK1/RIPK3 in the retinal ganglion cells (RGCs) cultured in high glucose
por: Gao, Sheng, et al.
Publicado: (2021)

RIPK1 and RIPK3 regulate TNFα-induced β-cell death in concert with caspase activity
por: Contreras, Christopher J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0bbn48g3i0l51hgrrdjco00dh5